Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HK1 | P19367 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10330351 | 0.91 | RAB9A (0.48) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL13910159 | 0.91 | RAB9A (0.48) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL13910153 | 0.89 | MAOB (0.47) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL14016423 | 0.88 | NPC1 (0.41) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL19075474 | 0.84 | GAA (0.41) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL5567189 | 0.84 | KDM4E (0.39) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21336168 | 0.81 | NPC1 (0.37) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21336154 | 0.77 | NPC1 (0.42) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL28035824 | 0.76 | NISCH (0.45) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL10122763 | 0.73 | NISCH (0.44) | NPC1ALDH1A1MAPTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8557953-B2 | Polymers comprising substituted anthracenyl units, blends comprising these polymers, and devices comprising these polymers or blends | MERCK PATENT GMBH (DE) | 2013-10-15 | — | — | US | disclosed |
| US-8212471-B2 | Light emitting device and electronic equipment provided with the light emitting device | SEIKO EPSON CORPORATION (JP) | 2012-07-03 | — | — | US | disclosed |
| US-20120108731-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-05-03 | — | — | US | disclosed |
| US-8012528-B2 | Applying a tetraaryldiamine compounds containing four acrylic or methacrylic ester groups, polymerizing the monomer; high reliability | SEIKO EPSON CORPORATION (JP) | 2011-09-06 | — | — | US | disclosed |
| US-7986085-B2 | Light emitting apparatus and electronic equipment provided with the light emitting apparatus | SEIKO EPSON CORPORATION (JP) | 2011-07-26 | — | — | US | disclosed |
| US-7910226-B2 | Porous semiconductor layer formation material | SEIKO EPSON CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7829639-B2 | photopolymerizable bis(glycidyl-substituted-diphenylamino) compounds; polyepoxides; organic light emitting; electroluminescent; thin film transistor; switch; charge transfer; high reliability; solubility | SEIKO EPSON CORPORATION (JP) | 2010-11-09 | — | — | US | disclosed |
| US-7683368-B2 | Method of manufacturing semiconductor element, semiconductor element, electronic device, and electronic equipment | SEIKO EPSON CORPORATION (JP) | 2010-03-23 | — | — | US | disclosed |
| US-7659043-B2 | Composition for conductive materials, conductive material, conductive layer, electronic device, and electronic equipment | SEIKO EPSON CORPORATION (JP) | 2010-02-09 | — | — | US | disclosed |
| US-20090284128-A1 | Light emitting apparatus and electronic equipment provided with the light emitting apparatus | SEIKO EPSON CORPORATION (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090140635-A1 | Porous semiconductor layer formation material | SEIKO EPSON CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090102359-A1 | Light emitting device and electronic equipment provided with the light emitting device | SEIKO EPSON CORPORATION (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20090088550-A1 | Composition for conductive materials, conductive material, conductive layer, electronic device, and electronic equipment | SEIKO EPSON CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090032807-A1 | Method of Manufacturing Semiconductor Element, Semiconductor Element, Electronic Device, and Electronic Equipment | SEIKO EPSON CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090009061-A1 | Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment | SEIKO EPSON CORPORATION (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20080107914-A1 | Composition for Conductive Materials Comprising Tetra Acrylate Functionalised Arylamines, Conductive Material and Layer, Electronic Device and Equipment | SEIKO EPSON CORPORATION (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20070286997-A1 | Material Composition for Conductive Layers in Electronic Devices | SEIKO EPSON CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070286997-A1 | Material Composition for Conductive Layers in Electronic Devices | C1S, KCNH3, SLC9A2 | NPC1 1582/4885ALDH1A1 2080/4885MAPT 4354/4885 |
| US-20090009061-A1 | Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment | AHR, SLC43A1, SLC1A2 | NPC1 2680/4885ALDH1A1 1236/4885MAPT 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.